Tenets of Protection from Progression to AIDS: Lessons from the Immune Responses to HIV-2 Infection
Overview
Affiliations
In the past 25 years, life survival curves of many countries have been remodeled owing to HIV infection. Both HIV-1 and HIV-2 can cause AIDS, yet patients infected with HIV-2 fare much better clinically and most will never experience detrimental effects of the infection. Despite over two decades of comprehensive research into vaccine development, a prophylactic vaccine is not yet realized. An essential missing link in the innovation of a successful vaccine strategy is the description of a favorable immune response that abolishes virus replication. Lessons learned from studying the role of the immune system in the long-term nonprogression characteristic of HIV-2 infection will offer insight into how a balanced immune response can protect from the destruction of the immune system associated with chronic HIV-1 infection.
Lungu C, Overmars R, Grundeken E, Boers P, van der Ende M, Mesplede T Viruses. 2023; 15(11).
PMID: 38005913 PMC: 10675771. DOI: 10.3390/v15112236.
Gao C, Ouyang W, Kutza J, Grimm T, Fields K, Lankford C Viruses. 2023; 15(11).
PMID: 38005838 PMC: 10674259. DOI: 10.3390/v15112160.
Human immunodeficiency virus type 2 infections in Austria.
Taylor N, Kern J, Prammer W, Lang A, Haas B, Gisinger M Wien Klin Wochenschr. 2014; 126(7-8):212-6.
PMID: 24442861 DOI: 10.1007/s00508-013-0493-1.
Viral factors in non-progression.
Wang B Front Immunol. 2014; 4:355.
PMID: 24400003 PMC: 3871964. DOI: 10.3389/fimmu.2013.00355.
Koup R, Graham B, Douek D Nat Rev Immunol. 2010; 11(1):65-70.
PMID: 21164527 DOI: 10.1038/nri2890.